Haisco Pharmaceutical Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Xiu Lian Fan
Chief executive officer
CN¥1.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.5yrs |
| CEO ownership | 23.4% |
| Management average tenure | no data |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
Is Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) Trading At A 38% Discount?
Dec 19
Haisco Pharmaceutical Group Co., Ltd.'s (SZSE:002653) Shares May Have Run Too Fast Too Soon
Nov 19Haisco Pharmaceutical Group's (SZSE:002653) Promising Earnings May Rest On Soft Foundations
Aug 22With Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) It Looks Like You'll Get What You Pay For
Jul 25Haisco Pharmaceutical Group (SZSE:002653) Has A Pretty Healthy Balance Sheet
Jul 04Calculating The Fair Value Of Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)
Jun 17These 4 Measures Indicate That Haisco Pharmaceutical Group (SZSE:002653) Is Using Debt Reasonably Well
Mar 19Risks To Shareholder Returns Are Elevated At These Prices For Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)
Feb 27CEO
Xiu Lian Fan (61 yo)
14.5yrs
Tenure
CN¥1,312,900
Compensation
Ms. Xiu Lian Fan is the Managing Director and General Manager at Haisco Pharmaceutical Group Co., Ltd (Former Name: Xizang Haisco Pharmaceutical Group Co., Ltd.) and serves as its Director since August 08,...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, GM & Director | 14.5yrs | CN¥1.31m | 23.42% CN¥ 7.8b | |
| Deputy GM & Director | 14.5yrs | CN¥780.00k | no data | |
| Deputy GM & Director | 3.3yrs | CN¥5.82m | 0.11% CN¥ 38.1m | |
| Chairman | 14.5yrs | CN¥1.77m | 36.02% CN¥ 12.1b | |
| Supervisor | 8.1yrs | no data | no data | |
| Independent Director | 8.1yrs | CN¥113.60k | no data | |
| Chairman of the Supervisory Board | 4.8yrs | CN¥215.50k | no data | |
| Independent Director | 8.1yrs | CN¥113.60k | no data | |
| Non-Employee Supervisor | 5.8yrs | no data | 0.000090% CN¥ 30.1k | |
| Independent Director | 4.8yrs | CN¥151.40k | no data | |
| Independent Director | 1.5yrs | CN¥40.00k | no data | |
| Independent Director | 1.5yrs | CN¥40.00k | no data |
7.0yrs
Average Tenure
55yo
Average Age
Experienced Board: 002653's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 17:16 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Haisco Pharmaceutical Group Co., Ltd. is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue Gao | Changjiang Securities Co. LTD. |
| Shanshan Li | China Merchants Securities Co. Ltd. |
| Sophia Zhang | China Stock Investment Research Co. Ltd. (GZ500..com) |